Bi-allelic variants in the ESAM tight-junction gene cause a neurodevelopmental disorder associated with fetal intracranial hemorrhage
- PMID: 36996813
- PMCID: PMC10119151
- DOI: 10.1016/j.ajhg.2023.03.005
Bi-allelic variants in the ESAM tight-junction gene cause a neurodevelopmental disorder associated with fetal intracranial hemorrhage
Abstract
The blood-brain barrier (BBB) is an essential gatekeeper for the central nervous system and incidence of neurodevelopmental disorders (NDDs) is higher in infants with a history of intracerebral hemorrhage (ICH). We discovered a rare disease trait in thirteen individuals, including four fetuses, from eight unrelated families associated with homozygous loss-of-function variant alleles of ESAM which encodes an endothelial cell adhesion molecule. The c.115del (p.Arg39Glyfs∗33) variant, identified in six individuals from four independent families of Southeastern Anatolia, severely impaired the in vitro tubulogenic process of endothelial colony-forming cells, recapitulating previous evidence in null mice, and caused lack of ESAM expression in the capillary endothelial cells of damaged brain. Affected individuals with bi-allelic ESAM variants showed profound global developmental delay/unspecified intellectual disability, epilepsy, absent or severely delayed speech, varying degrees of spasticity, ventriculomegaly, and ICH/cerebral calcifications, the latter being also observed in the fetuses. Phenotypic traits observed in individuals with bi-allelic ESAM variants overlap very closely with other known conditions characterized by endothelial dysfunction due to mutation of genes encoding tight junction molecules. Our findings emphasize the role of brain endothelial dysfunction in NDDs and contribute to the expansion of an emerging group of diseases that we propose to rename as "tightjunctionopathies."
Keywords: ESAM; blood-brain barrier; epilepsy; exome sequencing; global developmental delay; intellectual disability; intracranial hemorrhage; neurodevelopmental disorders; pregnancy loss; retinopathy; tight junctions.
Copyright © 2023 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests J.R.L. has stock ownership in 23andMe and is a paid consultant for the Regeneron Genetics Center.
Figures





References
-
- Olusanya B.O., Wright S.M., Nair M.K.C., Boo N.Y., Halpern R., Kuper H., Abubakar A.A., Almasri N.A., Arabloo J., Arora N.K., et al. Global burden of childhood epilepsy, intellectual disability, and sensory impairments. Pediatrics. 2020;146:e20192623. doi: 10.1542/peds.2019-2623. - DOI - PMC - PubMed
-
- Engbers H.M., Nievelstein R.A.J., Gooskens R.H.J.M., Kroes H.Y., van Empelen R., Braams O., Wittebol-Post D., Hendriks M.M.W.B., Visser G. The clinical utility of MRI in patients with neurodevelopmental disorders of unknown origin. Eur. J. Neurol. 2010;17:815–822. doi: 10.1111/j.1468-1331.2009.02927.x. - DOI - PubMed
-
- Mitani T., Isikay S., Gezdirici A., Gulec E.Y., Punetha J., Fatih J.M., Herman I., Akay G., Du H., Calame D.G., et al. High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population. Am. J. Hum. Genet. 2021;108:1981–2005. doi: 10.1016/j.ajhg.2021.08.009. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases